NCT00343551
- Conditions
- Cardiovascular Diseases, Essential Hypertension, Hypertension, +1 more
- Locations
-
- Investigative Centers, Germany
- Novartis Pharmaceuticals Basel, Switzerland
Clinical trial condition
Explore clinical trials studying Essential Hypertension. Study availability and eligibility vary by location and protocol.
NCT00343551
NCT01785472
NCT02738632
NCT02944734
NCT02938910
NCT00509470
NCT02322450
NCT00553865
NCT01701726
NCT02419235